Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus mutans biofilm is a structured microbial community formed by *S. mutans* on tooth surfaces, embedded in a self-produced extracellular matrix. This biofilm is a primary factor in the development of dental caries (tooth decay), as it enables *S. mutans* to adhere to teeth, metabolize dietary sugars, and produce acids that demineralize enamel. The biofilm formation process involves initial attachment, microcolony formation, maturation, regulation by multiple genes and quorum sensing mechanisms. Key molecular components include glucosyltransferases, fructosyltransferase, sortase A, Antigen I/II (P1/spaA), and LuxS. Factors like saliva and oxygen tension modulate biofilm development. Its resilience makes *S. mutans* difficult to eradicate, contributing to caries and complicating treatment strategies.
Disruption of biofilm structure, inhibition of bacterial adhesion, inhibition of acid production, targeting EPS synthesis, interference with quorum sensing.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus mutans Biofilm (S. mutans Biofilm).